[1]
|
Kalluri, R. (2016) The Biology and Function of Fibroblasts in Cancer. Nature Reviews Cancer, 16, 582-598.
https://doi.org/10.1038/nrc.2016.73
|
[2]
|
Krisnawan Varintra, E., Stanley Jennifer, A., Schwarz Julie, K. and De-Nardo David, G. (2020) Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stro-mal-Mediated Radioresistance. Cancers, 12, Article 2916. https://doi.org/10.3390/cancers12102916
|
[3]
|
Barker, H.E., Paget, J.T.E., Khan, A.A. and Harrington, K.J. (2015) The Tumourmicroenvironment after Radiotherapy: Mecha-nisms of Resistance and Recurrence. Nature Reviews Cancer, 15, 409-425. https://doi.org/10.1038/nrc3958
|
[4]
|
Weichselbaum, R.R., Liang, H., Deng, L. and Fu, Y.X. (2017) Radiotherapy and Immunotherapy: A Beneficial Liaison? Nature Reviews Clinical Oncology, 14, 365-379. https://doi.org/10.1038/nrclinonc.2016.211
|
[5]
|
Byrne, N.M., Tambe, P. and Coulter, J.A. (2021) Radiation Re-sponse in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives. Journal of Personalized Medi-cine, 11, Article 53.
https://doi.org/10.3390/jpm11010053
|
[6]
|
Leroi, N., Lallemand, F., Coucke, P., Noel, A. and Martinive, P. (2016) Impacts of Ionizing Radiation on the Differentcompartments of the Tumor Microenvironment. Frontiers in Pharmacolo-gy, 7, Article 78.
https://doi.org/10.3389/fphar.2016.00078
|
[7]
|
Jin, X., Ding, D., Yan, Y., et al. (2019) Phosphorylated RB Pro-motescancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression. Molecular Cell, 73, 22-35.E6. https://doi.org/10.1016/j.molcel.2018.10.034
|
[8]
|
Hou, Y., Liang, H., Rao, E., et al. (2018) Non-Canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy. Immunity, 49, 490-503.E4. https://doi.org/10.1016/j.immuni.2018.07.008
|
[9]
|
Kim, J.Y., Jeon, S., Yoo, Y.J., et al. (2019) The Hsp27-Mediated IkBαNFκB Signaling Axis Promotes Radiation-Induced Lung Fibrosis. Clinical Cancer Research, 25, 5364-5375. https://doi.org/10.1158/1078-0432.CCR-18-3900
|
[10]
|
Turley, S.J., Cremasco, V. and Astarita, J.L. (2015) Immunological Hallmarks of Stromal Cells in the Tumourmicroenvironment. Nature Reviews Immunology, 15, 669-682. https://doi.org/10.1038/nri3902
|
[11]
|
Bouquet, F., Pal, A., Pilones, K., et al. (2011) TGFβ1 Inhibition In-creases the Radiosensitivity of Breast Cancer Cells in Vitro and Promotes Tumor Control by Radiation in Vivo. Clinical Cancer Research, 17, 6754-6765.
https://doi.org/10.1158/1078-0432.CCR-11-0544
|
[12]
|
Morgan, A., Griffin, M., Kameni, L., Wan, D.C., Longaker, M.T. and Norton, J.A. (2023) Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer. Biology, 12, Arti-cle 1044. https://doi.org/10.3390/biology12081044
|
[13]
|
Chen, J., Zhu, H., Yin, Y., Jia, S. and Luo, X. (2022) Colorectal Cancer: Metabolic Interactions Reshape the Tumor Microenvironment. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1877, Article ID: 188797.
https://doi.org/10.1016/j.bbcan.2022.188797
|
[14]
|
Boelens, M.C., Wu, T.J., Nabet, B.Y., Xu, B., Qiu, Y., Yoon, T., Azzam, D.J., Twyman-Saint Victor, C., Wiemann, B.Z., Ishwaran, H., et al. (2014) Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapyresistance Pathways. Cell, 159, 499-513. https://doi.org/10.1016/j.cell.2014.09.051
|
[15]
|
Agosti, E., Panciani, P.P., Zeppieri, M., De Maria, L., Pasqualetti, F., Tel, A., Zanin, L., Fontanella, M.M. and Ius, T. (2023) Tumor Microenvironment and Glioblastoma Cell Interplay as Promoters of Therapeutic Resistance. Biology, 12, Article 736. https://doi.org/10.3390/biology12050736
|
[16]
|
Wang, Y., Gan, G., Wang, B., Wu, J., Cao, Y., Zhu, D., Xu, Y., Wang, X., Han, H., Li, X., et al. (2017) Cancer-Associated Fi-broblasts Promote Irradiated Cancer Cell Recovery through Autophagy. eBioMedicine, 17, 45-56.
https://doi.org/10.1016/j.ebiom.2017.02.019
|
[17]
|
Zhang, H., Yue, J., Jiang, Z., Zhou, R., Xie, R., Xu, Y. and Wu, S. (2017) CAF-Secreted CXCL1 Conferred Radioresistanceby Regulating DNA Damage Response in a ROS-Dependent Manner in Esophageal Squamous Cell Carcinoma. Cell Death & Disease, 8, e2790. https://doi.org/10.1038/cddis.2017.180
|
[18]
|
Al-Assar, O., Demiciorglu, F., Lunardi, S., Gaspar-Carvalho, M.M., McKenna, W.G., Muschel, R.M. and Brunner, T.B. (2014) Contextual Regulation of Pancreatic Cancer Stem Cell Phe-notype and Radioresistance Bypancreatic Stellate Cells. Radiotherapy & Oncology, 111, 243-251. https://doi.org/10.1016/j.radonc.2014.03.014
|
[19]
|
Hen, W.J., Ho, C.C., Chang, Y.L., Chen, H.Y., Lin, C.A., Ling, T.Y., Yu, S.L., Yuan, S.S., Louisa Chen, Y.J., Lin, C.Y., et al. (2014) Cancer-Associated Fibroblasts Regulate the Plas-ticity of Lung Cancer Stemness via Paracrinesignalling. Nature Communications, 5, Article No. 3472. https://doi.org/10.1038/ncomms4472
|
[20]
|
Osuka, S., Sampetrean, O., Shimizu, T., Saga, I., Onishi, N., Sugihara, E., Okubo, J., Fujita, S., Takano, S., Matsumura, A., et al. (2013) IGF1 Receptor Signaling Regulates Adaptive Radio-protection in Glioma Stem Cells. Stem Cells, 31, 627-640. https://doi.org/10.1002/stem.1328
|
[21]
|
Hawsawi, N.M., Ghebeh, H., Hendrayani, S.F., Tulbah, A., Al-Eid, M., Al-Tweigeri, T., Ajarim, D., Alaiya, A., Dermime, S. and Aboussekhra, A. (2008) Breast Carcinoma-Associated Fibroblasts and Their Counterparts Displayneoplastic-Specific Changes. Cancer Research, 68, 2717-2725. https://doi.org/10.1158/0008-5472.CAN-08-0192
|
[22]
|
Sahai, E., Astsaturov, I., Cukierman, E., et al. (2020) A Framework for Advancing Our Understanding of Cancer-As- sociated Fi-broblasts. Nature Reviews Cancer, 20, 174-186. https://doi.org/10.1038/s41568-019-0238-1
|
[23]
|
Li, D., Qu, C., Ning, Z., Wang, H., Zang, K., Zhuang, L., Chen, L., Wang, P. and Meng, Z. (2016) Radiation Promotesepitheli-al-to-Mesenchymal Transition and Invasion of Pancreatic Cancer Cell by Activating Carcinoma-Associated- fibroblasts. American Journal of Cancer Research, 6, 2192-2206.
|
[24]
|
Hellevik, T., Pettersen, I., Berg, V., Winberg, J.O., Moe, B.T., Bartnes, K., Paulssen, R.H., Busund, L.T., Bremnes, R., Chalmers, A., et al. (2012) Cancer-Associated Fibroblasts from Human NSCLC Survive Ablative Doses Ofradiation But Their Invasive Capacity Is Reduced. Radiation Oncology, 7, Article No. 59.
https://doi.org/10.1186/1748-717X-7-59
|
[25]
|
Mantoni, T.S., Lunardi, S., Al-Assar, O., Masamune, A. and Brun-ner, T.B. (2011) Pancreatic Stellate Cells Radioprotectpancreatic Cancer Cells through β1-Integrin Signaling. Cancer Re-search, 71, 3453-3458.
https://doi.org/10.1158/0008-5472.CAN-10-1633
|
[26]
|
Gilkes, D.M., Semenza, G.L. and Wirtz, D. (2014) Hypoxia and the Extracellular Matrix: Drivers of Tumour Metastasis. Nature Reviews Cancer, 14, 430-439. https://doi.org/10.1038/nrc3726
|
[27]
|
Cordes, N. (2006) Integrin-Mediated Cell-Matrix Interactions for Prosurvival and Antiapoptotic Signaling Aftergenotoxic Injury. Cancer Letters, 242, 11-19. https://doi.org/10.1016/j.canlet.2005.12.004
|
[28]
|
Cordes, N., Seidler, J., Durzok, R., Geinitz, H. and Brakebusch, C. (2006) B1-Integrin-Mediated Signaling EssentiallyContributes to Cell Survival after Radiation-Induced Genotoxic In-jury. Oncogene, 25, 1378-1390.
https://doi.org/10.1038/sj.onc.1209164
|
[29]
|
Biswas, S., Freeman, M.L., Arteaga, C.L., Biswas, S., Guix, M., Rinehart, C., Dugger, T.C., Chytil, A., Moses, H.L., Freeman, M.L., et al. (2007) Inhibition of TGF β with Neutralizing Antibodies Preventsradiation-Induced Acceleration of Metastatic Cancer Progression Find the Latest Version: Inhibition of TGF-β with Neutralizing Antibodies Prevents Radiation-Induced Acceleration of Metastatic. Journal of Clinical Inves-tigation, 117, 1305-1313.
https://doi.org/10.1172/JCI30740
|
[30]
|
Chetty, C., Bhoopathi, P., Rao, J.S. and Lakka, S.S. (2009) Inhibition of Matrix Metalloproteinase-2 Enhancesradiosensitivity by Abrogating Radiation-Induced FoxM1-Mediated G2/M Arrest in A549 Lung Cancer Cells. International Journal of Cancer, 124, 2468-2477. https://doi.org/10.1002/ijc.24209
|
[31]
|
Binnewies, M., Roberts, E.W., Kersten, K., Chan, V., Fearon, D.F., Merad, M., Coussens, L.M., Gabrilovich, D.I., Ostrand-Rosenberg, S., Hedrick, C.C., et al. (2018) Understanding the Tumor Immune Microenvironment (TIME) for Effective Therapy. Nature Medicine, 24, 541-550. https://doi.org/10.1038/s41591-018-0014-x
|
[32]
|
He, X., Feng, Z., Ma, J., et al. (2020) Bispecific and Split CAR T Cells Targeting CD13 and TIM3 Eradicate Acute Myeloid Leukemia. Blood, 135, 713-723. https://doi.org/10.1182/blood.2019002779
|
[33]
|
Daassi, D., Mahoney, K.M. and Freeman, G.J. (2020) The Im-portance of Exosomal PDL1 in Tumour Immune Evasion. Nature Reviews Immunology, 20, 209-215. https://doi.org/10.1038/s41577-019-0264-y
|
[34]
|
Meng, Y., et al. (2010) Blockade of Tumor Necrosis Factor α Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy. Cancer Research, 70, 1534-1543. https://doi.org/10.1158/0008-5472.CAN-09-2995
|
[35]
|
王珍, 茅芯慧, 章恒, 等. STAT3诱导巨噬细胞M2型极化促进宫颈癌细胞的放疗抵抗及机制研究[J]. 现代肿瘤医学, 2022, 30(15): 2710-2715.
|
[36]
|
Rahal, O.M., Wolfe, A.R., Mandal, P.K., Larson, R., Tin, S., Jimenez, C., Zhang, D., Horton, J., Reuben, J.M., McMurray, J.S. and Wood-ward, W.A. (2018) Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer. International Journal of Radiation Oncology, Biology, Physics, 100, 1034-1043.
https://doi.org/10.1016/j.ijrobp.2017.11.043
|
[37]
|
Formenti, S.C., Rudqvist, N.P., Golden, E., Cooper, B., Wenner-berg, E., Lhuillier, C., Vanpouille-Box, C., Friedman, K., Ferrari De Andrade, L., Wucherpfennig, K.W., et al. (2018) Radiotherapy Induces Responses of Lungcancer to CTLA-4 Blockade. Nature Medicine, 24, 1845-1851. https://doi.org/10.1038/s41591-018-0232-2
|
[38]
|
Sharabi, A.B., Nirschl, C.J., Kochel, C.M., Nirschl, T.R., Francica, B.J., Velarde, E., Deweese, T.L. and Drake, C.G. (2015) Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses Viacross-Presentation of Tumor Antigen. Cancer Immunology Research, 3, 345-355.
https://doi.org/10.1158/2326-6066.CIR-14-0196
|
[39]
|
Yoshimoto, Y., Suzuki, Y., Mimura, K., Ando, K., Oike, T., Sato, H., Okonogi, N., Maruyama, T., Izawa, S., Noda, S.E., et al. (2014) Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in A Mouse Model. PLOS ONE, 9, e92572.
https://doi.org/10.1371/journal.pone.0092572
|
[40]
|
Wang, Y., Liu, Z.G., Yuan, H., et al. (2019) The Reciprocity between Radiotherapy and Cancer Immunotherapy. Clinical Cancer Research, 25, 1709-1717. https://doi.org/10.1158/1078-0432.CCR-18-2581
|
[41]
|
Rodríguez-Ruiz, M.E., Vanpouille-Box, C., Melero, I., et al. (2018) Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect. Trends in Immunology, 39, 644-655. https://doi.org/10.1016/j.it.2018.06.001
|
[42]
|
Edner, N.M., Carlesso, G., Rush, J.S., et al. (2020) Target-ing Co-Stimulatory Molecules in Autoimmune Disease. Nature Reviews Drug Discovery, 19, 860-883. https://doi.org/10.1038/s41573-020-0081-9
|
[43]
|
Rodriguez-Ruiz, M.E., Rodriguez, I., Leaman, O., et al. (2019) Immune Mechanisms Mediating Abscopal Effects in Radioimmunotherapy. Pharmacology & Therapeutics, 196, 195-203. https://doi.org/10.1016/j.pharmthera.2018.12.002
|
[44]
|
Grapin, M., Richard, C., Limagne, E., et al. (2019) Optimized Fractionated Radiotherapy with Anti-PD-L1 and Anti-TIGIT: A Promising New Combination. Journal for ImmunoTherapy of Cancer, 7, 160.
https://doi.org/10.1186/s40425-019-0634-9
|
[45]
|
Soukup, K. and Wang, X. (2015) Radiation Meets Immunothera-py—A Perfect Match in the Era of Combination Therapy? International Journal of Radiation Biology, 91, 299-305. https://doi.org/10.3109/09553002.2014.995383
|
[46]
|
Frey, B., Rückert, M., Deloch, L., Rühle, P.F., Derer, A., Fietkau, R. and Gaipl, U.S. (2017) Immunomodulation Byionizing Radiation-Impact for Design of Ra-dio-Immunotherapies and for Treatment of Inflammatory Diseases. Immunological Reviews, 280, 231-248. https://doi.org/10.1111/imr.12572
|
[47]
|
Manda, K., Glasow, A., Paape, D. and Hildebrandt, G. (2012) Effects of Ionizing Radiation on the Immune System with Special Emphasis on the Interaction of Dendritic and T Cells. Frontiers in Oncology, 2, Article 102.
https://doi.org/10.3389/fonc.2012.00102
|
[48]
|
Falcke, S.E., Rühle, P.F., Deloch, L., Fietkau, R., Frey, B. and Gaipl, U.S. (2018) Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System. International Journal of Molecular Sciences, 19, Article 3574. https://doi.org/10.3390/ijms19113574
|
[49]
|
McKelvey, K.J., Hudson, A.L., Back, M., Eade, T. and Diakos, C.I. (2018) Radiation, Inflammation and the Immuneresponse in Cancer. Mammalian Genome, 29, 843-865. https://doi.org/10.1007/s00335-018-9777-0
|
[50]
|
Rubner, Y., Wunderlich, R., Rühle, P.F., Kulzer, L., Werthmöller, N., Frey, B., Weiss, E.M., Keilholz, L., Fietkau, R. and Gaipl, U.S. (2012) How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity? Frontiers in Oncology, 2, Article 75. https://doi.org/10.3389/fonc.2012.00075
|
[51]
|
Hall, E.J. and Giaccia, A.J. (2012) Radiobiology for the Radiologist. Lippincott Williams & Wilkins: Philadelphia.
|
[52]
|
Brown, J.M. and Wilson, W.R. (2004) Exploiting Tumour Hypoxia in Cancer Treatment. Nature Reviews Cancer, 4, 437-447. https://doi.org/10.1038/nrc1367
|
[53]
|
Movafagh, S., Crook, S. and Vo, K. (2015) Regulation of Hypoxia-Inducible Factor-1a by Reactive Oxygen Species: Newdevelopments in an Old Debate. Journal of Cellular Biochemistry, 116, 696-703.
https://doi.org/10.1002/jcb.25074
|
[54]
|
Wang, H., Jiang, H., Van De Gucht, M. and De Ridder, M. (2019) Hypoxic Radioresistance: Can ROS Be the Key to Overcome It? Cancers, 11, Article 112. https://doi.org/10.3390/cancers11010112
|
[55]
|
Smolarczyk, R., Cichon, T., Pilny, E., Jarosz-Biej, M., Poczkaj, A., Kułach, N. and Szala, S. (2018) Combination of Anti-Vascular Agent-DMXAA and HIF-1α Inhibitor-Digoxin Inhibits the Growth of Melanoma Tumors. Scientific Reports, 8, Article No. 7355. https://doi.org/10.1038/s41598-018-25688-y
|
[56]
|
Park, H.J., Griffin, R.J., Hui, S., Levitt, S.H. and Song, C.W. (2012) Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS). Radiation Research, 177, 311-327. https://doi.org/10.1667/RR2773.1
|
[57]
|
Riva, M., Wouters, R., Nittner, D., Ceuster, J., Sterpin, E., Giovannoni, R., Himmelreich, U., Gsell, W., Van Ranst, M. and Coosemans, A. (2020) Radiation Dose-Escalation and Dose-Fractionation Modulate the Immune Microenvironment, Cancer Stem Cells and Vasculaturein Experimental High-Grade Gliomas. Journal of Neurosurgical Sciences, 67, 55-65.
|
[58]
|
Maeda, A., Chen, Y., Bu, J., Mujcic, H., Wouters, B.G. and DaCosta, R.S. (2017) In Vivo Imaging Reveals Significant Tumor Vascular Dysfunction and Increased Tumor Hypoxia-Inducible Factor-1α Expression Induced by High Single-Dose Irradiation in a Pancreatic Tumor Model. International Journal of Radiation Oncology, Biology, Phys-ics, 97, 184-194. https://doi.org/10.1016/j.ijrobp.2016.09.005
|